ZAMA is trading at $0.071818, down 6.08% over 24 hours. The short-term price action is bearish: the reported 24-hour high is $0.078147, around 8.1% above the current price, and the supplied 7-day and 14-day changes are also negative.

There is an inconsistency in the 24-hour data: the current price is $0.000987 below the reported low of $0.072805. The stated high-to-low range of $0.005342 is consistent with those reported extremes, but the current price cannot be reconciled with that range, so the exact position within the day’s range is unclear.

All five listed hourly moving averages are above the current price, from $0.0764 for the 8- and 13-hour averages to $0.0818 for the 144-hour average. This alignment supports the bearish near-term reading; the supplied comparisons likewise show the averages above price, with the largest stated gap at the 144-hour average, at 12.24%.

The 1-hour RSI of 29 signals that recent short-term selling has been strong and puts the reading in oversold territory, which can allow for a rebound but does not confirm one. The 7-day RSI of 49 is close to neutral, tempering the extreme short-term reading rather than establishing a clear broader bullish or bearish momentum signal.

Momentum differs substantially by timeframe: ZAMA is up 43.97% over 30 days but down 7.09% over seven days and 21.98% over 14 days. The monthly gain is a meaningful positive counterweight, yet the sharper two-week loss suggests that recent weakness has erased some of that advance.

The 24-hour volume is 10,596,214, and volume is reported at 5.81% of market capitalization. Without a prior-volume comparison, these figures do not establish whether participation is increasing or unusually high, so they provide limited directional evidence.

ZAMA remains about 33.1% below its stated all-time high of $0.107368. That distance shows it has not recovered to its peak, but the supplied figures do not establish whether the high is a relevant near-term target or resistance level.

Overall rating: Hold. The 30-day gain and oversold 1-hour RSI argue against treating the supplied evidence as uniformly bearish, while the price decline across 24 hours, seven days and 14 days, together with price below every listed hourly moving average, weighs against a Buy.

The primary evidence supporting Hold is this conflict between a strong 30-day return and pronounced recent weakness, with the near-oversold hourly RSI offering a possible but unconfirmed offset. The 24-hour low inconsistency further limits confidence in reading the latest range, while the neutral 7-day RSI offers no strong directional confirmation.